Accepting Ideas that Lead to Improved ENT Care
Mr. Gatto is the founder of AMG Development a medical device consulting firm. His professional experience includes many different areas in the medical industry. He has been involved in areas ranging from product management to executive management. He acquired his knowledge of the medical device industry over the last twenty years from a hands on perspective.
He started as a product manager, soon to become head of marketing and product development, for one of the world's largest producers of medical textile products - CoNco Medical Corporation (now part of the Hartmann Group). Upon departing this large multi-national medical concern, he turned his interests to business development and was instrumental in building a small, developing medical device company (Merocel Corporation) into a world leader in its field of synthetic biocompatible polymers for use in microsurgical. In his next venture, he conducted a feasibility study to determine the viability of a new business division for minimally invasive medical devices. When he found that such a venture was worthwhile and could be developed, FessCo, Inc. was formed to design, develop, manufacture, and market minimally invasive ENT endoscopic devices. FessCo, a Delaware Corporation wholly owned by Warburg-Pincus, was financially successful within in its first 6 months of sales, exceeding over $2 million in revenues. He had successfully developed and launched a line of innovative minimally invasive handheld cutting instruments and a self-irrigating powered tissue shaver system, the first of its kind, for the ENT market. Within its third year of operation, FessCo, along with Merocel Corporation, were folded into Xomed Surgical Products and the operations eventually acquired by Medtronic.
After FessCo, his proven track record allowed him to obtain the necessary support to form a start-up entity, MedTrek Corporation, to design, develop, and market minimally invasive ENT devices. After establishing the innovative MedTrek product line and worldwide distribution rights for the products with Olympus, he divested his interest in MedTrek and joined the breast cancer start-up company Acueity, Inc. as Executive Vice President of Operations. He guided Acueity’s product development, sales, marketing and production. Under his leadership, Acueity was featured in Time magazine as one of the top five medical technologies for breast cancer detection and treatment. Since departing Acueity, he has been an executive advisor to startup Acclarent, Inc. (acquired by Johnson & Johnson). In addition, he served on the board of directors of Solos Endoscopy. During his career, he has developed, launched and successfully managed over 75 medical devices ranging from polymer based disposables to integrated imaging systems. He holds 5 patents and is co-inventor on three patent pending medical devices.
Mr. Gatto graduated Magna Cum Laude with a BS degree in Marketing from Quinnipiac University and attended the Executive Management program at the John E. Anderson School of Business – UCLA. He is currently an Entrepreneur in Residence at The University of Notre Dame’s Mendoza School of Business for entrepreneurial studies. Also, he recently was an entrepreneurial advisor for the NFL Player Engagement Program.
Dr. Kennedy is Professor of Otorhinolaryngology - Head and Neck Surgery at the University of Pennsylvania Health System and the past President of the American Academy of Otolaryngology—Head and Neck Surgery. Born in the British Isles, he attended medical school at the Royal College of Surgeons in Ireland, completed his residency in otolaryngology at Johns Hopkins Hospital and was subsequently appointed, in 1991, as chairman of the Department of Otorhinolaryngology - Head and Neck Surgery at the University of Pennsylvania. Dr. Kennedy introduced endoscopic sinus surgery in the U.S., and has taught its techniques throughout the world. He is also known for pioneering and developing instrumentation for endoscopic sinus surgery, and participation in the early development of image-guided surgery, as well as in the evolution of endoscopic skull base surgery and trans-nasal endoscopic orbital surgery.
A Co-Founder of FessCo, he has also served on the medical advisory board of Warburg-Pincus and multiple medical device and drug companies. He has contributed approximately 200 articles to the medical literature, largely related to sinusitis and research involving its management, and is the author of several books in this field. Dr. Kennedy has served in a variety of leadership positions at Johns Hopkins University, the University of Pennsylvania and its Health System, and internationally. He has participated on the boards of several major otolaryngology societies, as President of the American Rhinologic Society, the International Rhinologic Society, and is currently the Editor of the American Journal of Rhinology.
He has received numerous awards for his contributions to medicine, including a Presidential Citation from the American Academy of Otolaryngology, as well as the Practice Excellence Award from its Board of Governors, and the Lyons Memorial and Fitzsimmons Medals for surgery. In 1999, he was elected as a member of the Institute of Medicine of the National Academy of Sciences.
Dr. Kennedy has a strong interest in health care delivery, in the appropriate utilization of healthcare resources, and in providing the highest quality of healthcare both within the United States and internationally. Dr. Kennedy received the prestigious Castle Connolly National Physician of the Year Award for 2011.